RankingsPricing
  1. US-listed companies
  2. SANGAMO THERAPEUTICS, INC

SANGAMO THERAPEUTICS, INCSGMO

Market cap
$139.73M
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023
Cash and cash equivalents17221066922501408013117910045
Marketable securities-------260282510198177-
Marketable securities------------36
Interest receivable0000000011010
Accounts receivable143103535375641
Prepaid expenses and other current assets------25512161812
Total current assets86689719121315024841140566039930094
Marketable securities, non-current--------22518830-
Property and equipment, net22113731793041526427
Intangible assets-------5553585451-
Goodwill--22-224039434038-
Operating lease right-of-use assets--------7771736226
Other non-current assets---00053914151717
Restricted cash-------422222
Total assets8783141243217158287590638939722563165
Accounts payable---------13102215
Other accrued liabilities---------19121624
Accrued Employee Benefits, Current22333359142121229
Accrued Employee Benefits, Current22333359142121229
Other accrued liabilities---------19121624
Deferred revenues-------4839928652-
Total current liabilities791021201345797014412811248
Deferred revenues, non-current-------10881245167109-
Long-term portion of lease liabilities--------4138443934
Deferred income tax---------776-
Other non-current liabilities-------267111
Total liabilities-18193725229922320544134726882
Common Stock, Value, Issued1111111111122
Additional paid-in capital---5355615766839301,0911,2691,3341,4501,492
Accumulated deficit-253-276-302-329-369-441-495-563-657-778-956-1,148-1,406
Accumulated other comprehensive loss000-0-0-0-1-25-4-8-5
Total stockholders’ equity-------367433497375295-
Total stockholders’ equity806512220719213618836743349837529583
Total liabilities and stockholders’ equity8783141243217158287590638939722563165